122 related articles for article (PubMed ID: 22311635)
1. Developmentally regulated expression of MEF2C limits the response to BCR engagement in transitional B cells.
Andrews SF; Dai X; Ryu BY; Gulick T; Ramachandran B; Rawlings DJ
Eur J Immunol; 2012 May; 42(5):1327-36. PubMed ID: 22311635
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation.
Wilker PR; Kohyama M; Sandau MM; Albring JC; Nakagawa O; Schwarz JJ; Murphy KM
Nat Immunol; 2008 Jun; 9(6):603-12. PubMed ID: 18438409
[TBL] [Abstract][Full Text] [Related]
3. BCR-Induced Ca
Berry CT; Liu X; Myles A; Nandi S; Chen YH; Hershberg U; Brodsky IE; Cancro MP; Lengner CJ; May MJ; Freedman BD
Cell Rep; 2020 Apr; 31(2):107474. PubMed ID: 32294437
[TBL] [Abstract][Full Text] [Related]
4. A p38 MAPK-MEF2C pathway regulates B-cell proliferation.
Khiem D; Cyster JG; Schwarz JJ; Black BL
Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17067-72. PubMed ID: 18955699
[TBL] [Abstract][Full Text] [Related]
5. Transitional B cells exhibit a B cell receptor-specific nuclear defect in gene transcription.
Andrews SF; Rawlings DJ
J Immunol; 2009 Mar; 182(5):2868-78. PubMed ID: 19234182
[TBL] [Abstract][Full Text] [Related]
6. BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway.
Craxton A; Draves KE; Gruppi A; Clark EA
J Exp Med; 2005 Nov; 202(10):1363-74. PubMed ID: 16301744
[TBL] [Abstract][Full Text] [Related]
7. Regulation of lymphoid versus myeloid fate 'choice' by the transcription factor Mef2c.
Stehling-Sun S; Dade J; Nutt SL; DeKoter RP; Camargo FD
Nat Immunol; 2009 Mar; 10(3):289-96. PubMed ID: 19169261
[TBL] [Abstract][Full Text] [Related]
8. Essential control of early B-cell development by Mef2 transcription factors.
Herglotz J; Unrau L; Hauschildt F; Fischer M; Kriebitzsch N; Alawi M; Indenbirken D; Spohn M; Müller U; Ziegler M; Schuh W; Jäck HM; Stocking C
Blood; 2016 Feb; 127(5):572-81. PubMed ID: 26660426
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia.
Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; Macleod RA
Leuk Lymphoma; 2011 Feb; 52(2):290-7. PubMed ID: 21261500
[TBL] [Abstract][Full Text] [Related]
10. B Cell Development sans B Cell Receptor Responsiveness Due to Unfolded Protein Response-Triggered Mef2c Protein Degradation.
Chen YT; Su YC; Kung JT
J Immunol; 2018 Nov; 201(10):2885-2898. PubMed ID: 30305329
[TBL] [Abstract][Full Text] [Related]
11. mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo.
Dodou E; Xu SM; Black BL
Mech Dev; 2003 Sep; 120(9):1021-32. PubMed ID: 14550531
[TBL] [Abstract][Full Text] [Related]
12. Processing of CD74 by the Intramembrane Protease SPPL2a Is Critical for B Cell Receptor Signaling in Transitional B Cells.
Hüttl S; Kläsener K; Schweizer M; Schneppenheim J; Oberg HH; Kabelitz D; Reth M; Saftig P; Schröder B
J Immunol; 2015 Aug; 195(4):1548-63. PubMed ID: 26157172
[TBL] [Abstract][Full Text] [Related]
13. Requirement for JNK-dependent upregulation of BimL in anti-IgM-induced apoptosis in murine B lymphoma cell lines WEHI-231 and CH31.
Takada E; Hata K; Mizuguchi J
Exp Cell Res; 2006 Nov; 312(19):3728-38. PubMed ID: 17007835
[TBL] [Abstract][Full Text] [Related]
14. Regulation of A1/Bfl-1 expression in peripheral splenic B cells.
Trescol-Biémont MC; Verschelde C; Cottalorda A; Bonnefoy-Bérard N
Biochimie; 2004; 86(4-5):287-94. PubMed ID: 15194232
[TBL] [Abstract][Full Text] [Related]
15. Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer.
De Val S; Anderson JP; Heidt AB; Khiem D; Xu SM; Black BL
Dev Biol; 2004 Nov; 275(2):424-34. PubMed ID: 15501228
[TBL] [Abstract][Full Text] [Related]
16. Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis.
Gekas C; Rhodes KE; Gereige LM; Helgadottir H; Ferrari R; Kurdistani SK; Montecino-Rodriguez E; Bassel-Duby R; Olson E; Krivtsov AV; Armstrong S; Orkin SH; Pellegrini M; Mikkola HK
Blood; 2009 Apr; 113(15):3461-71. PubMed ID: 19211936
[TBL] [Abstract][Full Text] [Related]
17. The novel adaptor protein Swiprosin-1 enhances BCR signals and contributes to BCR-induced apoptosis.
Avramidou A; Kroczek C; Lang C; Schuh W; Jäck HM; Mielenz D
Cell Death Differ; 2007 Nov; 14(11):1936-47. PubMed ID: 17673920
[TBL] [Abstract][Full Text] [Related]
18. Bim regulates BCR-induced entry of B cells into the cell cycle.
Craxton A; Draves KE; Clark EA
Eur J Immunol; 2007 Oct; 37(10):2715-22. PubMed ID: 17705137
[TBL] [Abstract][Full Text] [Related]
19. BAFF receptor signaling aids the differentiation of immature B cells into transitional B cells following tonic BCR signaling.
Rowland SL; Leahy KF; Halverson R; Torres RM; Pelanda R
J Immunol; 2010 Oct; 185(8):4570-81. PubMed ID: 20861359
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor induces MEF2C and MEF2-dependent activity in endothelial cells.
Maiti D; Xu Z; Duh EJ
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3640-8. PubMed ID: 18450586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
